Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education

Journal of Clinical Lipidology

Volumn 7, Issue 5, 2013, Pages 472-483

  Wei, Melissa Y ^a   Ito, Matthew K ^b   Cohen, Jerome D ^c   Brinton, Eliot A ^d   Jacobson, Terry A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Utah Foundation for Biomedical Research   (United States)

Author keywords

Adherence; Cholesterol; Compliance; Muscle symptoms; Myalgia; Side effects; Statin

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DRUG COST; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; FEMALE; HEALTH SURVEY; HUMAN; INCOME; INTERNET; MAJOR CLINICAL STUDY; MALE; MYALGIA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; UNITED STATES;

ADHERENCE; CHOLESTEROL; COMPLIANCE; MUSCLE SYMPTOMS; MYALGIA; SIDE EFFECTS; STATIN;

ADULT; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; UNITED STATES; WITHHOLDING TREATMENT;

EID: 84885018297     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2013.03.001     Document Type: Article

References (29)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
2. C. Baigent, A. Keech, and P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
3. G. Tripepi, K.J. Jager, and F.W. Dekker Selection bias and information bias in clinical research Nephron Clin Pract 115 2010 c94 c99
4. A.R. Jadad Randomized Controlled Trials: A User's Guide 1998 BMJ Publishing Group London
5. J. Downs, M. Clearfield, and S. Weis Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS JAMA 279 1998 1615 1622
6. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20.536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 9326 2002 7 22
7. J.S. Benner, R.J. Glynn, and H. Mogun Long-term persistence in use of statin therapy in elderly patients JAMA 288 2002 455 461
8. M.H. Davidson, K.C. Maki, and T.A. Pearson Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations Am J Cardiol 96 2005 556 563
9. Centers for Disease Control and Prevention Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol-United States, 1999-2002 and 2005-200 Morb Mortal Wkly Rep 60 2011 109 114
10. A. Mauskop, and W.B. Borden Predictors of statin adherence Curr Cardiol Rep 13 2011 553 558
11. D.C. Chan, W.H. Shrank, and D. Cutler Patient, physician, and payment predictors of statin adherence Med Care 48 2010 196 202
12. D.M. Mann, M. Woodward, and P. Muntner Predictors of non-adherence to statins: a systematic review and meta-analysis Ann Pharmacother 44 2010 1410 1421
13. A.H. Traylor, J.A. Schmittdiel, and C.S. Uratsu Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter? J Gen Intern Med 25 2010 1172 1177
14. J.D. Cohen, E.A. Brinton, M.K. Ito, and T.A. Jacobson Understanding Statin Use in America and Gaps in Patient Education (USAGE): an Internet-based survey of 10,138 current and former statin users J Clin Lipidol 6 2012 208 215
15. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
16. U.S. Census Bureau: State and country quickfacts. Available at: http://quickfacts.census.gov/qfd/states/00000.html. Accessed September 30, 2012.
17. C.A. Jackevicius, M. Mamdani, and J.V. Tu Adherence with statin therapy in elderly patients with and without acute coronary syndromes JAMA 288 2002 462 467
18. D.L. Esposti, S. Saragoni, and P. Batacchi Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis Clin Ther 34 2012 190 199
19. D.G. Pittman, W. Chen, and S.J. Bowlin Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations Am J Cardiol 107 2011 1662 1666
20. E. Bruckert, G. Hayem, and S. Dejager Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients - the PRIMO Study Cardiovasc Drugs Ther 19 2005 403 414
21. T.A. Jacobson Toward "pain-free" statin prescribing: A clinical algorithm for diagnosis and management of myalgias Mayo Clin Proc 83 2008 687 700
22. T.R. Bates, V.M. Connaughton, and G.F. Watts Non-adherence to statin therapy: a major challenge for preventive cardiology Exp Opin Pharmacother 10 2009 2973 2985
23. C.H. Harper, and T.A. Jacobson Avoiding statin myopathy: understanding key drug interactions Clin Lipidol 6 2011 1 10
24. SEARCH Collaborative Group SLCO1B1 variants and statin-induced myopathy-a genomewide study N Engl J Med 359 2008 789 799
25. J.N. Fuertes, A. Mislowack, and J. Bennett The physician-patient working alliance Patient Educ Couns 66 2007 29 36
26. C.A. McHorney The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease Curr Med Res Opin 25 2009 215 238
27. C.A. McHorney, C.V. Spain, C.M. Alexander, and J. Simmons Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims Clin Ther 31 2009 2584 2607
28. S.M. Cohen, and M. Kataoka-Yahiro Provider adherence to clinical guidelines related to lipid-lowering medications Mil Med 175 2010 122 126
29. J.J. Ellis, S.R. Erickson, and J.G. Stevenson Suboptimal statin adherence and discontinuation in primary and secondary prevention populations J Gen Intern Med 19 2004 638 645